Quality of Life of Patients with Type 1 Diabetes Mellitus Using Insulin Analog Glargine Compared with NPH Insulin: A Systematic Review and Policy Implications

INTRODUCTION: Insulin analog glargine (GLA) has been available as one of the therapeutic options for patients with type 1 diabetes mellitus to enhance glycemic control. Studies have shown that a decrease in the frequency of hypoglycemic episodes improves the quality of life (QoL) of diabetic patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Almeida, Paulo H. R. F., Silva, Thales B. C., de Assis Acurcio, Francisco, Guerra Júnior, Augusto A., Araújo, Vania E., Diniz, Leonardo M., Godman, Brian, Almeida, Alessandra M., Alvares, Juliana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019415/
https://www.ncbi.nlm.nih.gov/pubmed/29322308
http://dx.doi.org/10.1007/s40271-017-0291-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019415/
https://www.ncbi.nlm.nih.gov/pubmed/29322308
http://dx.doi.org/10.1007/s40271-017-0291-3

Ejemplares similares